Quick Answer
DNA X, Inc. reported Shares Outstanding of 4.98 million shares for fiscal year 2024.
DNA X, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2024 | 4.98M | +12.6% |
| 2023 | 4.43M | -89.1% |
| 2022 | 40.77M | +116.8% |
| 2021 | 18.81M | +183.6% |
| 2020 | 6.63M | -67.6% |
| 2019 | 20.44M | +31.1% |
| 2018 | 15.59M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.02M | -79.2% | -90.2% |
| June 30, 2025 | 10.34M | +114.2% | +63.2% |
| March 31, 2025 | 6.33M | -85.3% | +2187.5% |
| December 31, 2024 | 276,881 | -93.7% | -94.3% |
| September 30, 2024 | 4.87M | -88.6% | +0.9% |
| June 30, 2024 | 4.83M | -88.3% | -88.8% |
| March 31, 2024 | 43.21M | +5.4% | +876.0% |
| December 31, 2023 | 4.43M | -89.1% | -89.6% |
- DNA X, Inc. showed an increase of +12.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2024 period, DNA X, Inc.’s shares outstanding has declined by 68.0% (from 15.59 million shares to 4.98 million shares).
- The most recent figure is from DNA X, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: